FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Report of Foreign Issuer

     Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934

For the month of October 2006

Commission File Number: 001-15152

SYNGENTA AG
(Translation of registrant’s name into English)

Schwarzwaldallee 215
 4058 Basel
Switzerland
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F   X               Form 40-F      

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes        No   X  

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes        No   X  

Indicate by check mark whether by furnishing the information contained in this Form, the Registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

Yes        No   X  

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A





Re: SYNGENTA AG
  Press Release: “Syngenta obtains first regulatory approvals for new fungicide Revus”

Filed herewith is a press release related to Syngenta AG. The full text of the press release follows:

# # #





    Item 1
     
  Syngenta International AG
Media Office
CH-4002 Basel
Switzerland
Telephone: +41 61 323 23 23
Fax: +41 61 323 24 24
www.syngenta.com
     

Media Release
 

Syngenta obtains first regulatory approvals for new fungicide Revus™

Basel, Switzerland, October 3, 2006

Syngenta announced today that its new fungicide Revus™, developed under the code 446, has received its first registrations in Europe (Austria) and Asia (South Korea). Further registrations in other markets are targeted for the 2007 season. Global peak sales are expected to exceed $100 million annually.

Revus sets new standards providing best-in-class, weatherproof and long-lasting protection against late blight in potatoes and tomatoes, as well as downy mildew in vines and vegetable crops. Results from a large number of field trials conducted around the world show that Revus provides consistent performance even under extreme disease pressure.

“Revus is a significant innovation for growers. This new technology further strengthens Syngenta’s leading fungicide portfolio for high-value crops offering growers a complete range of disease control solutions” said John Atkin, Chief Operating Officer of Syngenta Crop Protection. “We already successfully launched two new products, Axial® and Avicta®, for the 2006 season, Revus is the third and we have another five crop protection products planned for launch by 2012.”

Syngenta is a world-leading agribusiness committed to sustainable agriculture through innovative research and technology. The company is a leader in crop protection, and ranks third in the high-value commercial seeds market. Sales in 2005 were approximately $8.1 billion. Syngenta employs more than 19,000 people in over 90 countries. Syngenta is listed on the Swiss stock exchange (SYNN) and in New York (SYT). Further information is available at www.syngenta.com.

Media Enquiries: Switzerland:   Médard Schoenmaeckers Tel: +41 (61) 323 2323
  USA:   Sarah Hull Tel: +1 (202) 628 2372
  UK:   Andrew Coker Tel: +44 (1344) 41 4503
         
Analysts/Investors: Switzerland:   Jonathan Seabrook Tel:+41 (61) 323 7502
      Jennifer Gough Tel:+41 (61) 323 5059
  USA:   Rhonda Chiger Tel:+1 (917)322 2569
 
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SYNGENTA AG
       
Date: October 3, 2006 By: /s/ Damian Heller
Name: Damian Heller
Title: Company Secretary